Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update
20 août 2019 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic,...
Cancer Genetics, Inc. Announces Strategic Transactions
15 juil. 2019 16h22 HE
|
Cancer Genetics, Inc.
Sale of BioPharma business to Interpace Diagnostics Group, Inc. Clinical services business acquired by siParadigm Diagnostic Informatics Significantly reduces its debt burden and will continue to...
Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update
20 mai 2019 17h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics,...
Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates
16 avr. 2019 07h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics,...
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
31 janv. 2019 16h01 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock
28 janv. 2019 22h33 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
28 janv. 2019 16h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics Issues Letter to Shareholders
16 janv. 2019 08h45 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
14 janv. 2019 17h29 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
09 janv. 2019 23h20 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...